• Endocrine regulation and hormone therapy emerged as a central research thread, linking steroid metabolism, estrogenic preparations, and endocrine responses to ovarian function and cancer risk across multiple tissues. Evidence spans pregnanediol-like glucuronide biology, vaginal enzyme activity, estrogenic therapy, and menopausal hormone indices [8], [13], [18], [14], [15], [19].

• Diagnostic and biomarker advances focused on enabling detection of reproductive pathology via cytology and biochemical markers in genital secretions, highlighting vaginal/secretions cytology for uterine cancer and enzymatic profiling of vaginal fluids [4], [1], [13].

• Surgical and pelvic health evolution is reflected in early 1950s reports on urinary incontinence and urethral diverticula, with reconstructive approaches and outcome-oriented procedural studies driving pelvic medicine forward [2], [3], [6].

• Male reproductive physiology and fertility interventions were advanced by in vitro pharmacology of the vasa deferentia, along with surgical fertility restoration and vas deferens anastomosis, illustrating a clear male-focused research stream [5], [7], [9], [12].

• Clinical and rare-case studies—from hermaphroditism to pseudocyesis and anorchism—shaped understanding of developmental and endocrinological aspects of reproduction, highlighting the breadth of reproductive science beyond common gynecologic pathologies [10], [19], [12].